» Articles » PMID: 22403417

Multicytokine Detection Improves Latent Tuberculosis Diagnosis in Health Care Workers

Overview
Specialty Microbiology
Date 2012 Mar 10
PMID 22403417
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

In a low-incidence setting, health care workers (HCW) are at a higher risk of tuberculosis than the general population. The suboptimal sensitivity of the QuantiFERON-TB Gold In-Tube (QFT) test remains a critical issue when identifying occupational latent tuberculosis infection (LTBI) in HCW. The aim of this study was to identify additional biomarkers in order to overcome the limits of gamma interferon (IFN-γ) release assays (IGRAs) and improve the performance of LTBI diagnosis within this population. Seventy Bacille Calmette-Guérin-vaccinated HCW regularly exposed to Mycobacterium tuberculosis were grouped according to QFT results into an LTBI-positive group (positive QFT, n = 8), an LTBI-negative group (normal QFT and negative tuberculin skin test [TST], n = 21), and an undetermined group (subpositive QFT and/or positive TST, n = 41). The secretion of 22 cytokines in response to QFT-specific stimulation was quantified using a multiparameter-based immunoassay. As a result, thresholds discriminating LTBI-positive from LTBI-negative HCW were established by comparing areas under the receiver operating characteristic curves for interleukin-2 (IL-2), IL-15, IFN-γ-induced protein 10 (IP-10), and the monokine induced by IFN-γ (MIG), which are biomarkers differentially secreted by the two groups. The combination of IL-15 and MIG provided a sensitivity of 100% and a specificity of 94.1% in distinguishing LTBI-positive from LTBI-negative HCW. When using IL-15 and MIG among the undetermined group, 6/45 HCW could be classified in the LTBI-positive group. The use of additional biomarkers after IGRA screening could improve the diagnosis of LTBI. The performance of these biomarkers and their use in combination with TST and/or QFT, as well as the cost-effectiveness of such a diagnostic strategy, should be evaluated in further larger clinical trials.

Citing Articles

Association of Mycobacterium tuberculosis aerosolization and HIV coinfection in the index case with T cell responses in household contacts.

Njagi L, Nduba V, Murithi W, Mwongera Z, Cook K, Mecha J Sci Rep. 2025; 15(1):224.

PMID: 39748008 PMC: 11695726. DOI: 10.1038/s41598-024-83965-5.


Household contact antigen-specic TNF and IL-2 T-cell responses and impact of index case Mycobacterium tuberculosis aerosolization and HIV Co-infection.

Njagi L, Nduba V, Murithi W, Mwongera Z, Cook K, Mecha J Res Sq. 2024; .

PMID: 39606489 PMC: 11601854. DOI: 10.21203/rs.3.rs-4815117/v1.


Biomarkers to identify infection among borderline QuantiFERON results.

Uzorka J, Bakker J, van Meijgaarden K, Leyten E, Delfos N, Hetem D Eur Respir J. 2022; 60(2).

PMID: 35058249 PMC: 9363845. DOI: 10.1183/13993003.02665-2021.


Is interleukin-2 an optimal marker for diagnosing tuberculosis infection? A systematic review and meta-analysis.

Qiu X, Wang H, Tang Y, Su X, Ge L, Qu Y Ann Med. 2020; 52(7):376-385.

PMID: 32700645 PMC: 7877967. DOI: 10.1080/07853890.2020.1800073.


Gaps in Study Design for Immune Parameter Research for Latent Tuberculosis Infection: A Systematic Review.

Herrera M, Vera C, Keynan Y, Rueda Z J Immunol Res. 2020; 2020:8074183.

PMID: 32377537 PMC: 7191376. DOI: 10.1155/2020/8074183.


References
1.
Menzies D, Joshi R, Pai M . Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis. 2007; 11(6):593-605. View

2.
Waldmann T, Tagaya Y, Bamford R . Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol. 1998; 16(3-4):205-26. DOI: 10.3109/08830189809042995. View

3.
Ling D, Pai M, Davids V, Brunet L, Lenders L, Meldau R . Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?. Eur Respir J. 2011; 38(3):649-56. PMC: 5463537. DOI: 10.1183/09031936.00181610. View

4.
Fox B, Kramer M, Mor Z, Preiss R, Rusanov V, Fuks L . The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis. Lung. 2009; 187(6):413-9. DOI: 10.1007/s00408-009-9182-2. View

5.
Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori G . Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2010; 37(1):100-11. DOI: 10.1183/09031936.00114810. View